Literature DB >> 24998462

Infection with Saint Louis encephalitis virus in the city of Ribeirao Preto, Brazil: report of one case.

Felipe Gonçalves Motta Maia1, Juliana Helena Chávez1, William Marciel de Souza2, Marilia Farignoli Romeiro1, Luiza Antunes de Castro-Jorge1, Benedito Antônio Lopes da Fonseca1, Luiz Tadeu Moraes Figueiredo3.   

Abstract

Saint Louis encephalitis virus (SLEV) is a mosquito-borne flavivirus from the Americas. In this report we describe aspects of the laboratory diagnosis of a patient with an acute febrile illness induced by SLEV that was initially diagnosed as dengue by positive IgM-ELISA. Infection with this virus is probably not rare in Brazil, but cases remain undiagnosed. It is necessary to improve the surveillance system, including laboratories, for the diagnosis of SLEV in Brazil.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Arbovirus; Brazil; Flavivirus; Saint Louis encephalitis virus

Mesh:

Year:  2014        PMID: 24998462     DOI: 10.1016/j.ijid.2014.05.018

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  2 in total

1.  SAINT LOUIS ENCEPHALITIS VIRUS IN MATO GROSSO, CENTRAL-WESTERN BRAZIL.

Authors:  Letícia Borges da Silva Heinen; Nayara Zuchi; Otacília Pereira Serra; Belgath Fernandes Cardoso; Breno Herman Ferreira Gondim; Marcelo Adriano Mendes Dos Santos; Francisco José Dutra Souto; Daphine Ariadne Jesus de Paula; Valéria Dutra; Renata Dezengrini-Slhessarenko
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 May-Jun       Impact factor: 1.846

2.  Screening of febrile patients with suspected malaria from the Brazilian Amazon for virus infection.

Authors:  Marcus Vinícius Guimarães Lacerda; Victor Hugo Aquino; Mario Luis Garcia de Figueiredo; Evan P Williams; Colleen B Jonsson; Mohd Jaseem Khan; Márcio Roberto Teixeira Nunes; Clayton Pereira Silva de Lima; Luiz Tadeu Moraes Figueiredo; Mônica Regina Farias Costa; Maria Paula Gomes Mourão
Journal:  Arch Virol       Date:  2022-07-16       Impact factor: 2.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.